Viatris VTRS
NASDAQ VTRS
$16.13 -0.12 (-0.74%)
At close: Aug 20, 2026 · 2:56 PM UTC

Viatris (VTRS) EBITDA Margin Growth (5y) (2024 - 2026)

Viatris (VTRS) EBITDA Margin Growth (5y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.94 Bn 42.97 Bn -
2 Teva Pharmaceutical Industries 43.08 Bn 39.43 Bn 2.15 Bn
3 Zoetis 31.54 Bn 29.87 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn
5 United Therapeutics 22.12 Bn 19.46 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn -
10 Alkermes 8.09 Bn 7.43 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 121.00
Mar 31, 2026 378.00
Dec 31, 2025 1,916.00
Mar 31, 2025 -9,570.00
Dec 31, 2024 -1,107.00